Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#assertion>. }
Showing items 1 to 9 of
9
with 100 items per page.
- association type Statement assertion.
- association label ""The use of Zileuton Extended-Release Tablets is contraindicated in patients with: Active liver disease or persistent hepatic function enzyme elevations greater than or equal to 3 times the upper limit of normal (>=3xULN) [see Warnings and Precautions (5) Use in Specific Populations (8.7) A history of allergic reaction to zileuton or any of the ingredients of Zileuton Extended Release Tablets (e.g., rash, eosinophilia, etc.). Active liver disease or persistent hepatic function enzyme elevations >=3 times the upper limit of normal. ( 4 5.1 History of allergic reaction to Zileuton or any of the ingredients of Zileuton Extended-Release Tablets. ( 4"" assertion.
- association subject drugbank:DB00744 assertion.
- association predicate treats assertion.
- association object DOID_409 assertion.
- association relation MedicalContraindication assertion.
- drugbank:DB00744 category Drug assertion.
- DOID_409 category Disease assertion.
- association provided_by NeuroDKG assertion.